Will you have Hypovolaemic shock with Ondansetron - from FDA reports

Summary

Hypovolaemic shock is found among people who take Ondansetron, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Dexamethasone, and have Abdominal pain. This study is created by eHealthMe based on reports of 46,783 people who have side effects when taking Ondansetron from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on ondansetron (the active ingredients of Ondansetron) and Ondansetron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Hypovolaemic shock are also considered in the study.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. (latest outcomes from Ondansetron 47,113 users)

What is Hypovolaemic shock?

Hypovolaemic shock (shock caused by severe blood or fluid loss) has been reported by people with atrial fibrillation/flutter, high blood pressure, stroke, pain, rheumatoid arthritis (latest reports from 3,539 Hypovolaemic shock patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

46,783 people reported to have side effects when taking Ondansetron.
Among them, 52 people (0.11%) have Hypovolaemic shock


Number of reports submitted per year:

Could Ondansetron cause Hypovolaemic shock?

Time on Ondansetron when people have Hypovolaemic shock *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hypovolaemic shock when taking Ondansetron *:

  • female: 22 %
  • male: 78 %

Age of people who have Hypovolaemic shock when taking Ondansetron *:

  • 0-1: 0.0 %
  • 2-9: 2.08 %
  • 10-19: 6.25 %
  • 20-29: 4.17 %
  • 30-39: 2.08 %
  • 40-49: 20.83 %
  • 50-59: 22.92 %
  • 60+: 41.67 %

Top conditions involved for these people *:

  1. Abdominal Pain: 8 people, 15.38%
  2. Gastric Cancer (stomach cancer): 7 people, 13.46%
  3. Diarrhea: 4 people, 7.69%
  4. Chest Pain: 4 people, 7.69%
  5. High Blood Cholesterol: 4 people, 7.69%
  6. High Blood Pressure: 4 people, 7.69%
  7. Lung Cancer - Non-Small Cell (lung cancer): 3 people, 5.77%
  8. Fever: 3 people, 5.77%
  9. Non-Small Cell Lung Cancer Stage Iii: 3 people, 5.77%
  10. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 3 people, 5.77%

Top co-used drugs for these people *:

  1. Dexamethasone: 14 people, 26.92%
  2. Cisplatin: 13 people, 25.00%
  3. Ranitidine: 12 people, 23.08%
  4. Camptosar: 7 people, 13.46%
  5. Morphine: 6 people, 11.54%
  6. Acetaminophen: 6 people, 11.54%
  7. Pantoprazole: 5 people, 9.62%
  8. Atropine: 4 people, 7.69%
  9. Lomotil: 4 people, 7.69%
  10. Etoposide: 4 people, 7.69%

Top other side effects for these people *:

  1. Renal Failure Acute (rapid kidney dysfunction): 23 people, 44.23%
  2. Diarrhea: 17 people, 32.69%
  3. Hypotension (abnormally low blood pressure): 15 people, 28.85%
  4. Dehydration (dryness resulting from the removal of water): 9 people, 17.31%
  5. Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 15.38%
  6. Septic Shock (shock due to blood infection): 7 people, 13.46%
  7. Metabolic Encephalopathy (disorder or disease of the brain due to the body's disability to use energy): 7 people, 13.46%
  8. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 6 people, 11.54%
  9. Malignant Neoplasm Progression (cancer tumour came back): 6 people, 11.54%
  10. Thrombocytopenia (decrease of platelets in blood): 6 people, 11.54%

* Approximation only. Some reports may have incomplete information.


Do you have Hypovolaemic shock while taking Ondansetron?

You are not alone:




Related studies

Drugs that are associated with Hypovolaemic shock
Hypovolaemic shock (733 drugs)
Could your condition cause Hypovolaemic shock
Hypovolaemic shock (474 conditions)
Ondansetron side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Ondansetron
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Ondansetron with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Ondansetron and have Hypovolaemic shock



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.